taurine has been researched along with Glioblastoma in 5 studies
Glioblastoma: A malignant form of astrocytoma histologically characterized by pleomorphism of cells, nuclear atypia, microhemorrhage, and necrosis. They may arise in any region of the central nervous system, with a predilection for the cerebral hemispheres, basal ganglia, and commissural pathways. Clinical presentation most frequently occurs in the fifth or sixth decade of life with focal neurologic signs or seizures.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The combination treatment is a way to improve the therapeutic strategy of temozolomide (TMZ) -resistant glioblastoma (GBM)." | 8.02 | Synergistic Effects of Taurine and Temozolomide Via Cell Proliferation Inhibition and Apoptotic Induction on U-251 MG Human Glioblastoma Cells. ( Chantree, P; Sangpairoj, K; Surarak, T, 2021) |
| "The combination treatment is a way to improve the therapeutic strategy of temozolomide (TMZ) -resistant glioblastoma (GBM)." | 4.02 | Synergistic Effects of Taurine and Temozolomide Via Cell Proliferation Inhibition and Apoptotic Induction on U-251 MG Human Glioblastoma Cells. ( Chantree, P; Sangpairoj, K; Surarak, T, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Surarak, T | 1 |
| Chantree, P | 1 |
| Sangpairoj, K | 1 |
| Bergenheim, AT | 1 |
| Roslin, M | 1 |
| Ungerstedt, U | 1 |
| Waldenström, A | 1 |
| Henriksson, R | 1 |
| Ronquist, G | 1 |
| Stendel, R | 1 |
| Scheurer, L | 1 |
| Schlatterer, K | 1 |
| Stalder, U | 1 |
| Pfirrmann, RW | 1 |
| Fiss, I | 1 |
| Möhler, H | 1 |
| Bigler, L | 1 |
| De Micheli, E | 1 |
| Alfieri, A | 1 |
| Pinna, G | 1 |
| Bianchi, L | 1 |
| Colivicchi, MA | 1 |
| Melani, A | 1 |
| Pedata, F | 1 |
| Della Corte, L | 1 |
| Bricolo, A | 1 |
| Whittle, IR | 1 |
| MacPherson, JS | 1 |
| Miller, JD | 1 |
| Smyth, JF | 1 |
1 trial available for taurine and Glioblastoma
| Article | Year |
|---|---|
Metabolic manipulation of glioblastoma in vivo by retrograde microdialysis of L-2, 4 diaminobutyric acid (DAB).
Topics: Aged; Aminobutyrates; Antimetabolites, Antineoplastic; Brain Neoplasms; Catheters, Indwelling; Dose- | 2006 |
4 other studies available for taurine and Glioblastoma
| Article | Year |
|---|---|
Synergistic Effects of Taurine and Temozolomide Via Cell Proliferation Inhibition and Apoptotic Induction on U-251 MG Human Glioblastoma Cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cell Proliferation; G2 | 2021 |
Pharmacokinetics of taurolidine following repeated intravenous infusions measured by HPLC-ESI-MS/MS of the derivatives taurultame and taurinamide in glioblastoma patients.
Topics: Adult; Aged; Antineoplastic Agents; Chromatography, High Pressure Liquid; Cyclic S-Oxides; Drug Admi | 2007 |
Extracellular levels of taurine in tumoral, peritumoral and normal brain tissue in patients with malignant glioma: an intraoperative microdialysis study.
Topics: Amino Acids; Brain; Brain Neoplasms; Extracellular Space; Female; Glioblastoma; Glioma; Humans; Male | 2000 |
The disposition of TCNU (tauromustine) in human malignant glioma: pharmacokinetic studies and clinical implications.
Topics: Adult; Aged; Antineoplastic Agents; Astrocytoma; Brain; Brain Neoplasms; Female; Glioblastoma; Human | 1990 |